Dr. Konety on Guidelines for the Management of Bladder Cancer

Badrinath Konety, MD, MBA
Published: Thursday, Oct 05, 2017



Badrinath Konety, MD, MBA, department chair, Department of Urology, University of Minnesota, discusses the guidelines for the management of patients with bladder cancer.

The National Comprehensive Cancer Network (NCCN), the American Urological Association (AUA), the European Association of Urology (EAU), and the NICE Guidance Statements are just 4 of the guidelines for the treatment and management of bladder cancer, explains Konety. These guidelines have been recently updated to include new clinical data.

These guidelines continue to be challenged and updated based on what is practical in the field, states Konety.



Badrinath Konety, MD, MBA, department chair, Department of Urology, University of Minnesota, discusses the guidelines for the management of patients with bladder cancer.

The National Comprehensive Cancer Network (NCCN), the American Urological Association (AUA), the European Association of Urology (EAU), and the NICE Guidance Statements are just 4 of the guidelines for the treatment and management of bladder cancer, explains Konety. These guidelines have been recently updated to include new clinical data.

These guidelines continue to be challenged and updated based on what is practical in the field, states Konety.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x